Cargando…
Recent Findings in Onychomycosis and Their Application for Appropriate Treatment
Onychomycosis is mainly caused by two dermatophyte species, Trichophyton rubrum and Trichophyton interdigitale. A study of nail invasion mechanisms revealed that the secreted subtilisin Sub6, which has never been detected under in vitro growth conditions, was the main protease secreted by T. rubrum...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463057/ https://www.ncbi.nlm.nih.gov/pubmed/30813287 http://dx.doi.org/10.3390/jof5010020 |
_version_ | 1783410691404726272 |
---|---|
author | Monod, Michel Méhul, Bruno |
author_facet | Monod, Michel Méhul, Bruno |
author_sort | Monod, Michel |
collection | PubMed |
description | Onychomycosis is mainly caused by two dermatophyte species, Trichophyton rubrum and Trichophyton interdigitale. A study of nail invasion mechanisms revealed that the secreted subtilisin Sub6, which has never been detected under in vitro growth conditions, was the main protease secreted by T. rubrum and T. interdigitale during infection. In contrast, most of the proteases secreted during the digestion of keratin in vitro were not detected in infected nails. The hypothesis that proteases isolated from dermatophytes grown in a keratin medium are virulence factors is no longer supported. Non-dermatophyte fungi can also be infectious agents in nails. It is necessary to identify the infectious fungus in onychomycosis to prescribe adequate treatment, as moulds such as Fusarium spp. and Aspergillus spp. are insensitive to standard treatments with terbinafine or itraconazole, which are usually applied for dermatophytes. In these refractory cases, topical amphotericin B treatment has shown to be effective. Terbinafine treatment failure against dermatophytes is also possible, and is usually due to resistance caused by a missense mutation in the squalene epoxidase enzyme targeted by the drug. Trichophyton resistance to terbinafine treatment is an emerging problem, and a switch to azole-based treatment may be necessary to cure such cases of onychomycosis. |
format | Online Article Text |
id | pubmed-6463057 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-64630572019-04-17 Recent Findings in Onychomycosis and Their Application for Appropriate Treatment Monod, Michel Méhul, Bruno J Fungi (Basel) Review Onychomycosis is mainly caused by two dermatophyte species, Trichophyton rubrum and Trichophyton interdigitale. A study of nail invasion mechanisms revealed that the secreted subtilisin Sub6, which has never been detected under in vitro growth conditions, was the main protease secreted by T. rubrum and T. interdigitale during infection. In contrast, most of the proteases secreted during the digestion of keratin in vitro were not detected in infected nails. The hypothesis that proteases isolated from dermatophytes grown in a keratin medium are virulence factors is no longer supported. Non-dermatophyte fungi can also be infectious agents in nails. It is necessary to identify the infectious fungus in onychomycosis to prescribe adequate treatment, as moulds such as Fusarium spp. and Aspergillus spp. are insensitive to standard treatments with terbinafine or itraconazole, which are usually applied for dermatophytes. In these refractory cases, topical amphotericin B treatment has shown to be effective. Terbinafine treatment failure against dermatophytes is also possible, and is usually due to resistance caused by a missense mutation in the squalene epoxidase enzyme targeted by the drug. Trichophyton resistance to terbinafine treatment is an emerging problem, and a switch to azole-based treatment may be necessary to cure such cases of onychomycosis. MDPI 2019-02-22 /pmc/articles/PMC6463057/ /pubmed/30813287 http://dx.doi.org/10.3390/jof5010020 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Monod, Michel Méhul, Bruno Recent Findings in Onychomycosis and Their Application for Appropriate Treatment |
title | Recent Findings in Onychomycosis and Their Application for Appropriate Treatment |
title_full | Recent Findings in Onychomycosis and Their Application for Appropriate Treatment |
title_fullStr | Recent Findings in Onychomycosis and Their Application for Appropriate Treatment |
title_full_unstemmed | Recent Findings in Onychomycosis and Their Application for Appropriate Treatment |
title_short | Recent Findings in Onychomycosis and Their Application for Appropriate Treatment |
title_sort | recent findings in onychomycosis and their application for appropriate treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463057/ https://www.ncbi.nlm.nih.gov/pubmed/30813287 http://dx.doi.org/10.3390/jof5010020 |
work_keys_str_mv | AT monodmichel recentfindingsinonychomycosisandtheirapplicationforappropriatetreatment AT mehulbruno recentfindingsinonychomycosisandtheirapplicationforappropriatetreatment |